Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-12 Sale |
2023-06-14 6:58 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
44,020 | $2.5513 | $112,307 | 5,100,302 (Indirect Direct) |
View |
2023-06-07 Sale |
2023-06-09 5:41 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
141,062 | $2.428 | $342,504 | 5,123,822 (Indirect Direct) |
View |
2023-06-05 Sale |
2023-06-07 6:24 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
33,390 | $2.5262 | $84,350 | 5,264,884 (Indirect Direct) |
View |
2023-06-01 Sale |
2023-06-05 4:21 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
31,531 | $2.5306 | $79,793 | 5,298,274 (Indirect Direct) |
View |
2023-04-21 Sale |
2023-04-25 5:50 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
15,004 | $2.3481 | $35,231 | 5,329,805 (Indirect Direct) |
View |
2023-04-19 Sale |
2023-04-21 07:57 am |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
68,743 | $2.2747 | $156,369 | 5,344,809 (Indirect Direct) |
View |
2023-04-17 Sale |
2023-04-19 09:22 am |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
148,982 | $2.1434 | $319,334 | 5,413,552 (Indirect Direct) |
View |
2023-03-17 Sale(A) |
2023-04-07 4:25 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
10,436 | $2.0643 | $21,543 | 5,562,534 (Indirect Direct) |
View |
2023-03-03 Sale(A) |
2023-04-07 4:23 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
6,806 | $2.0559 | $13,992 | 5,572,970 (Indirect Direct) |
View |
2023-03-01 Sale(A) |
2023-04-07 4:21 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
29 | $2.05 | $59 | 5,579,776 (Indirect Direct) |
View |
2023-02-21 Sale(A) |
2023-04-07 4:19 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
3,500 | $2.0529 | $7,185 | 5,579,805 (Indirect Direct) |
View |
2023-02-16 Sale(A) |
2023-04-07 4:17 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
6,551 | $2.0525 | $13,446 | 5,583,305 (Indirect Direct) |
View |
2023-03-17 Sale |
2023-03-20 4:36 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
10,436 | $2.0643 | $21,543 | 5,562,534 (Indirect Direct) |
View |
2023-03-03 Sale |
2023-03-07 4:58 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
6,806 | $2.0559 | $13,992 | 5,572,970 (Indirect Direct) |
View |
2023-03-01 Sale |
2023-03-02 5:26 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
29 | $2.05 | $59 | 5,579,776 (Indirect Direct) |
View |
2023-02-21 Sale |
2023-02-23 5:01 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
3,500 | $2.0529 | $7,185 | 5,579,805 (Indirect Direct) |
View |
2023-02-16 Sale |
2023-02-21 11:16 am |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
6,551 | $2.0525 | $13,446 | 5,583,305 (Indirect Direct) |
View |
2022-07-19 Purchase(A) |
2022-09-13 4:27 pm |
Talaris Therapeutics Inc. | TALS | Nader Francois Director |
138,500 | $3.6103 | $500,020 | 1,160,796 (Indirect Direct) |
View |
2022-08-22 Sale |
2022-08-23 7:43 pm |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Chief Scientific Officer |
525,000 | $2.8 | $1,470,000 | 5,589,856 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-07-03 Tax Withholding |
2023-07-06 5:20 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer |
12,946 | $3.08 | 68,054 (Direct) |
View |
2023-07-03 Tax Withholding |
2023-07-06 5:19 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Former Chief Executive Officer |
11,786 | $3.08 | 1,028,169 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 7:03 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Srivastava Sapna Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 7:02 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Smith Karen L. Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 7:01 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Shah Gaurav Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 7:00 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Nader Francois Director |
41,000 | $0 | 41,000 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 6:59 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | MCDADE MARK Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 6:59 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | MACKAY GEOFFREY Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 6:58 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director |
20,500 | $0 | 5,100,302 (Direct) |
View |
2023-06-13 Option Award |
2023-06-14 6:56 pm |
N/A 2033-06-13 |
Talaris Therapeutics Inc. | TALS | Agarwala Sandip Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 5:02 pm |
N/A 2033-02-01 |
Talaris Therapeutics Inc. | TALS | Zdanowski Michael Chief Technology Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2022-12-30 Option Award |
2023-02-03 5:01 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
4 | $0.867 | 1,679,959 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A 2033-02-01 |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
640,000 | $0 | 1,679,959 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:59 pm |
N/A 2033-02-01 |
Talaris Therapeutics Inc. | TALS | Krieger Nancy Chief Medical Officer |
240,000 | $0 | 240,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:57 pm |
N/A 2033-02-01 |
Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2022-09-10 Option Award |
2022-09-13 4:31 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Zdanowski Michael Chief Technology Officer |
120,000 | $0 | 121,470 (Direct) |
View |
2022-09-10 Option Award |
2022-09-13 4:30 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Krieger Nancy Chief Medical Officer |
80,000 | $0 | 330,233 (Direct) |
View |
2022-09-10 Option Award |
2022-09-13 4:30 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Requadt Scott Chief Executive Officer |
80,000 | $0 | 1,039,955 (Direct) |
View |
2022-09-10 Option Award |
2022-09-13 4:29 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Fenton Mary Kay Chief Financial Officer |
80,000 | $0 | 81,000 (Direct) |
View |
2022-07-21 Other(A) |
2022-09-13 4:27 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Nader Francois Director |
386,932 | $0 | 1,160,796 (Indirect) |
View |